Gabe Amo - Reproductive Freedom for All

Formerly NARAL Pro-Choice America

Reproductive Freedom for All

Donate

Menu

Back to Search

Congressional Record on Reproductive Freedom

Gabe Amo

House Democrat

Gabe Amo

Rhode Island RI-01

Connect with this lawmaker

N/A

2023 Score

Voting Record

  • Positively impacts reproductive freedom
  • Negatively impacts reproductive freedom
Year Key Vote How They Voted
yea

Vote for/in favor of

nay

Vote against

—

Abstained, absent, ineligible, present, resigned or deceased

L

Leader switched vote to preserve right to file a motion to reconsider

S

The speaker exercised their discretion not to vote

 Their Vote Impact
2023
Penalizing FDA for Expanding Mifepristone Access 7

Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024, H.R.4368. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Regulatory Policy at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Penalizing FDA for Expanding Mifepristone Access 6

Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024, H.R.4368. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Medical Policy at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Penalizing FDA for Expanding Mifepristone Access 5

Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Compliance at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Prohibiting Funding for the White House Gender Policy Council

Financial Services and General Government Appropriations Act, 2024, H.R.4664. Harshbarger (R-TN) amendment to eliminate funding for the White House Gender Policy Council which is charged with advancing gender equity and equality, including reproductive freedom. A vote for reproductive freedom was against the amendment.

 		—
2023
Penalizing FDA for Expanding Mifepristone Access 4

Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of New Drugs at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

—
2023
Penalizing FDA for Expanding Mifepristone Access 3

Penalizing FDA for Expanding Mifepristone Access. Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Division of Risk Management at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Penalizing FDA for Expanding Mifepristone Access 2

Penalizing FDA for Expanding Mifepristone Access. Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Office of Surveillance and Epidemiology at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Penalizing FDA for Expanding Mifepristone Access 1

Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations Act, 2024. Good (R-VA) amendment to reduce to $1 the salary of the Director of the Center for Drug Evaluation and Research at the FDA as part of ongoing attempts to limit access to mifepristone by targeting trained experts for their scientific and medical decision making. A vote for reproductive freedom was against the amendment.

 		—
2023
Prohibiting Funding for the Office of Population Affairs

Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2024. Miller (R-IL) amendment to eliminate funding for the Office of Population Affairs which administers critical reproductive health programs. A vote for reproductive freedom was against the amendment.

 		nay
2023
Resolution on Fake Health Centers

A resolution condemning violence against anti-abortion fake health centers and failing to recognize the real threats and attacks against reproductive health care providers and clinics, H.Con.Res.3.

—
2023
Attack on Servicemembers’ Access to Abortion: Jackson Amendment

National Defense Authorization Act for Fiscal Year 2024, H.R.2670. Jackson (R-TX) amendment to repeal the Department of Defense leave and travel policy that eases the burden of the statutory restrictions that force servicemembers and dependents to travel to access reproductive health care, including abortion services. A vote for reproductive freedom was against the amendment.

 		—
2023
Attack on Servicemembers’ Access to Abortion: Final Passage

National Defense Authorization Act for Fiscal Year 2024. Final Passage. A bill to authorize funding for certain defense, military, and national security programs which repeals the Department of Defense leave and travel policy that eases the burden of the statutory restrictions that force servicemembers and dependents to travel to access reproductive health care, including abortion services. (Some lawmakers who oppose reproductive freedom cast what appear to be votes in support of reproductive freedom; most observers recognize that those votes were cast for reasons unrelated to reproductive health.) A vote for reproductive freedom was against the bill.

 		—
2023
Interference in Abortion Practice

Born-Alive Abortion Survivors Protection Act, H.R.26. Wagner (R-MO) bill to interfere with the medical practice of abortion care under the threat of severe penalties.

 		—

Reproductive Freedom for All

Donate

Menu